Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2020

Feb 27, 2020

33819_dirs_2020-02-27_7df2bd40-ccf6-4630-bc07-da361d6e108d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2020-02-25

Reporting Person: Gadot Harel (Director, Chairman, President and CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-25 Stock Option (Right to Buy) $9.64 A 166666 Acquired 2030-02-25 Common Stock, par value $0.01 per share (166666) Direct